{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
A.  Khan, Akhtar, S., Ahmad, J. N., and Sarkar, D., ?Presence of a functional nitrate assimilation pathway in mycobacterium smegmatis?, Microbial Pathogenesis, vol. 44, no. 1, pp. 71-77, 2008.\par \par D.  Sreekanth, Syed, A., Sarkar, S., Sarkar, D., Santhakumari, B., Ahmad, A., and Khan, M. Islam, ?Production, purification, and characterization of taxol and 10-DABIII from a new endophytic fungus gliocladium sp isolated from the Indian yew tree, taxus baccata?, Journal of Microbiology and Biotechnology, vol. 19, no. 11, pp. 1342-1347, 2009.\par \par R. R.  Kulkarni, Shurpali, K., Gawade, R. L., Sarkar, D., Puranik, V. G., and Joshi, S. P., ?Phyllocladane diterpenes from anisomeles heyneana?, Journal of Asian Natural Products Research, vol. 14, no. 12, pp. 1162-1168, 2012.\par \par S.  Sarkar and Sarkar, D., ?Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of mycobacterium tuberculosis in a THP1 infection model?, Journal of Biomolecular Screening, vol. 17, no. 7, pp. 966-973, 2012.\par \par R.  Singh, Nawale, L., Arkile, M. A., Wadhwani, S., Shedbalkar, U., Chopade, S., Sarkar, D., and Chopade, B. Ananda, ?Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents?, International Journal of Nanomedicine, vol. 11, p. 1889?1897, 2016.\par \par R. Balasaheb Aher and Sarkar, D., ?Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating Mycobacterium tuberculosis?, Journal of Biomolecular Structure & Dynamics, vol. 39, no. 3, pp. 889-900, 2021.\par \par A.  Yeware, Akhtar, S., and Sarkar, D., ?Probes and techniques used in active and the hypoxia-based dormant state of an antitubercular drug screening assay?, Medicine in Drug Discovery, vol. 13, p. 100115, 2022.\par \par }